First Time Loading...

Jiangsu Chinagreen Biological Technology Co Ltd
SZSE:300970

Watchlist Manager
Jiangsu Chinagreen Biological Technology Co Ltd Logo
Jiangsu Chinagreen Biological Technology Co Ltd
SZSE:300970
Watchlist
Price: 12.13 CNY 4.57% Market Closed
Updated: Jun 10, 2024

Jiangsu Chinagreen Biological Technology Co Ltd
Accounts Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Jiangsu Chinagreen Biological Technology Co Ltd
Accounts Receivables Peer Comparison

Comparables:
600438
H
600598
B
002385
000876
002157

Competitive Accounts Receivables Analysis
Latest Figures & CAGR of Competitors

Company Accounts Receivables CAGR 3Y CAGR 5Y CAGR 10Y
Jiangsu Chinagreen Biological Technology Co Ltd
SZSE:300970
Accounts Receivables
¥18.7m
CAGR 3-Years
6%
CAGR 5-Years
5%
CAGR 10-Years
N/A
Tongwei Co Ltd
SSE:600438
Accounts Receivables
¥7.5B
CAGR 3-Years
50%
CAGR 5-Years
39%
CAGR 10-Years
40%
H
Heilongjiang Agriculture Co Ltd
SSE:600598
Accounts Receivables
¥10.9m
CAGR 3-Years
-6%
CAGR 5-Years
-19%
CAGR 10-Years
-33%
B
Beijing Dabeinong Technology Group Co Ltd
SZSE:002385
Accounts Receivables
¥1.2B
CAGR 3-Years
0%
CAGR 5-Years
-10%
CAGR 10-Years
3%
New Hope Liuhe Co Ltd
SZSE:000876
Accounts Receivables
¥1.3B
CAGR 3-Years
-2%
CAGR 5-Years
7%
CAGR 10-Years
6%
Jiangxi Zhengbang Technology Co Ltd
SZSE:002157
Accounts Receivables
¥122.4m
CAGR 3-Years
-35%
CAGR 5-Years
-27%
CAGR 10-Years
-8%

See Also

What is Jiangsu Chinagreen Biological Technology Co Ltd's Accounts Receivables?
Accounts Receivables
18.7m CNY

Based on the financial report for Dec 31, 2023, Jiangsu Chinagreen Biological Technology Co Ltd's Accounts Receivables amounts to 18.7m CNY.

What is Jiangsu Chinagreen Biological Technology Co Ltd's Accounts Receivables growth rate?
Accounts Receivables CAGR 5Y
5%

Over the last year, the Accounts Receivables growth was 50%. The average annual Accounts Receivables growth rates for Jiangsu Chinagreen Biological Technology Co Ltd have been 6% over the past three years , 5% over the past five years .